Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goetz H Kloecker

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
Hepatoid adenocarcinoma of the lung: report of five cases and review of the literatureDiana M Haninger, Goetz H Kloecker, Michael Bousamra Ii, et al.
Journal of Oncology|March 28, 2013
Detection of Immunoglobulin G against E7 of Human Papillomavirus in Non-Small-Cell Lung CancerRaul Storey, Joongho Joh, Amy Kwon, et al.
Cancer Biology & Therapy|June 22, 2007
A phase I study of thalidomide, capecitabine and temozolomide in advanced cancerDamian A Laber, M Iltaf Khan, Goetz H Kloecker, et al.
Journal of Oncology Practice|January 14, 2017
Phase II Trial on Extending the Maintenance Flushing Interval of Implanted PortsJorge A Diaz, Shesh N Rai, Xiaoyoung Wu, et al.
American Journal of Clinical Oncology|May 20, 2009
Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessaryMichael V Jaglal, Damian A Laber, Forest W Arnold, et al.
Experimental and Molecular Pathology|August 12, 2010
Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancerJoongho Joh, A Bennett Jenson, Grace D Moore, et al.
Oncotarget|October 10, 2014
CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisPranav Gupta, Praveen K Sharma, Hina Mir, et al.
Cancer Management and Research|February 9, 2018
Treatment and outcomes of non-small-cell lung cancer patients with high comorbidityJorge Rios, Rahul Gosain, Bernardo Hl Goulart, et al.
Journal of Cancer Research and Clinical Oncology|June 3, 2006
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanomaDamian A Laber, Roseline I Okeke, Carlos Arce-Lara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2010
Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancerJoan H Schiller, Joachim von Pawel, Philipp Schütt, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
Hepatoid adenocarcinoma of the lung: report of five cases and review of the literatureDiana M Haninger, Goetz H Kloecker, Michael Bousamra Ii, et al.
Journal of Oncology|March 28, 2013
Detection of Immunoglobulin G against E7 of Human Papillomavirus in Non-Small-Cell Lung CancerRaul Storey, Joongho Joh, Amy Kwon, et al.
Cancer Biology & Therapy|June 22, 2007
A phase I study of thalidomide, capecitabine and temozolomide in advanced cancerDamian A Laber, M Iltaf Khan, Goetz H Kloecker, et al.
Journal of Oncology Practice|January 14, 2017
Phase II Trial on Extending the Maintenance Flushing Interval of Implanted PortsJorge A Diaz, Shesh N Rai, Xiaoyoung Wu, et al.
American Journal of Clinical Oncology|May 20, 2009
Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessaryMichael V Jaglal, Damian A Laber, Forest W Arnold, et al.
Experimental and Molecular Pathology|August 12, 2010
Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancerJoongho Joh, A Bennett Jenson, Grace D Moore, et al.
Oncotarget|October 10, 2014
CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisPranav Gupta, Praveen K Sharma, Hina Mir, et al.
Cancer Management and Research|February 9, 2018
Treatment and outcomes of non-small-cell lung cancer patients with high comorbidityJorge Rios, Rahul Gosain, Bernardo Hl Goulart, et al.
Journal of Cancer Research and Clinical Oncology|June 3, 2006
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanomaDamian A Laber, Roseline I Okeke, Carlos Arce-Lara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2010
Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancerJoan H Schiller, Joachim von Pawel, Philipp Schütt, et al.
Pageof 3